tradingkey.logo

BRIEF-Lipocine Receives Updated Regulatory Guidance on LPCN 1154

ReutersFeb 6, 2025 1:37 PM

- Lipocine LPCN.O:

  • LIPOCINE RECEIVES UPDATED REGULATORY GUIDANCE ON LPCN 1154

  • LIPOCINE INC - FDA REQUIRES EFFICACY AND SAFETY STUDY FOR LPCN 1154 NDA SUBMISSION

  • LIPOCINE INC - PLANS PHASE 3 SAFETY AND EFFICACY STUDY FOR LPCN 1154

Source text: ID:nPn78Pz7Fa

Further company coverage: LPCN.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI